Skip to main content

e-Poster

Showing 1 of 1

New

Nirsevimab real-world evidence: effectiveness, public health impact and safety from 2 years of post-marketing experience

Confidential. For use by Medical Affairs for scientific exchange purposes only. Do not copy or distribute. Some information may not be consistent with the approved product labelling for the product(s) being discussed; this information may relate to the indication or use, dosage and administration, patient population, combination use, or other potential unapproved uses. No conclusions regarding safety and efficacy can be made for such uses.